Advertisement
Implementation of a new model of care can improve outcomes of care in medical and surgical units

New Model of Inpatient Care Can Improve Outcomes

0
Model aims to up interprofessional collaboration, data-driven decisions, provide leadership
Teens who use abuse prescription drugs such as opioids are more likely to have sex or to participate in risky sexual behaviors

Abuse of Prescription Drugs Ups Sexual Risks for Teens

0
Those taking these drugs with no prescription more likely to have multiple partners, forgo condom use
Alecensa (alectinib) has been approved by the U.S. Food and Drug administration to treat anaplastic lymphoma kinase-positive non-small-cell lung cancer

FDA Approves Alecensa for ALK-Positive NSCLC

0
Drug is designed to block the effects of the ALK protein
Patients with rheumatoid arthritis have increased herpes zoster risk with older age and higher prednisone dose

Herpes Zoster Risk in RA Up With Older Age, Prednisone Dose

0
HZ risk comparable after initiation of TNFi, non-TNFi, and conventional synthetic DMARDs
Seven behaviors should be implemented to improve the art of medicine

Seven Behaviors Suggested to Improve ‘Art of Medicine’

0
Seven behaviors promote more consistent practice of interpersonal aspects of medicine
Pharmaceutical industry-sponsored studies are more likely to report favorable estimates in cost-effectiveness analysis of drugs used in breast cancer treatment

Industry-Led Oncology Trials May Inflate Cost-Effectiveness

0
Breast cancer cost-effectiveness analyses show favorable estimates with industry funding
For patients with non-small-cell lung cancer

Toxic Skin Effects Common With EGFR-TKI Use in NSCLC

0
Afatinib therapy linked to earlier paronychia onset; more dermatological visits for skin toxic effects
Postmenopausal women with hormone receptor-positive ductal carcinoma in situ have similar recurrence rates of disease whether they take tamoxifen or the aromatase inhibitor anastrozole after surgery

SABCS: Tamoxifen, Anastrozole Both Prevent Recurrence in DCIS

0
However, side effects differ for the two medications
Vistogard (uridine triacetate) has been approved by the U.S. Food and Drug Administration to treat an overdose of the chemotherapy drugs fluorouracil and capecitabine

FDA Approves Vistogard to Treat Chemotherapy Overdose

0
For overdose of the chemo drugs fluorouracil and capecitabine
For statin-intolerant patients with dyslipidemia with ischemic heart disease treated with percutaneous coronary intervention

Nutraceuticals Alone or With Ezetimibe Aid in Dyslipidemia

0
Improvement in lipid profile for nutraceuticals alone or in combo for statin-intolerant patients